Investigators from the Department of Functional Neurology, Epileptology and Epilepsy Institute (IDEE), and the Lyon’s University Hospital examined the clinical determinants of ADHD severity in children with epilepsy (CWE) along with the response to treatment with methylphenidate (MPH)
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Predictors of response to methylphenidate (MPH) among 47 children with ADHD and mental retardation (...
Investigators from Great Ormond Street Hospital, and Institute of Child Health, London, UK, reviewed...
ADHD occurs in about 30% of children with epilepsy. The causes of ADHD features include some antiepi...
Attention deficit hyperactivity disorder (ADHD) is more frequent in children with epilepsy than in g...
Background: Methylphenidate (MPH) is the most commonly used medication for Attention-Deficit/Hypera...
The detection and treatment of both attention deficit/hyperactivity disorder (ADHD) and epilepsy in ...
The effects of methylphenidate in thirty children, ages 6 to 16, with epilepsy and ADHD were evaluat...
Researchers at University Children’s Hospital Basel, and other centers in Switzerland, Norway, and G...
BackgroundThe present study was dedicated to investigate the influence of Methylphenidate (MPH) on c...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy an...
The effects of methylphenidate in ten children with attention deficit complicated by seizure disorde...
AbstractPurposeThe knowledge about possible relationships between ADHD and epilepsy is largely based...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Predictors of response to methylphenidate (MPH) among 47 children with ADHD and mental retardation (...
Investigators from Great Ormond Street Hospital, and Institute of Child Health, London, UK, reviewed...
ADHD occurs in about 30% of children with epilepsy. The causes of ADHD features include some antiepi...
Attention deficit hyperactivity disorder (ADHD) is more frequent in children with epilepsy than in g...
Background: Methylphenidate (MPH) is the most commonly used medication for Attention-Deficit/Hypera...
The detection and treatment of both attention deficit/hyperactivity disorder (ADHD) and epilepsy in ...
The effects of methylphenidate in thirty children, ages 6 to 16, with epilepsy and ADHD were evaluat...
Researchers at University Children’s Hospital Basel, and other centers in Switzerland, Norway, and G...
BackgroundThe present study was dedicated to investigate the influence of Methylphenidate (MPH) on c...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy an...
The effects of methylphenidate in ten children with attention deficit complicated by seizure disorde...
AbstractPurposeThe knowledge about possible relationships between ADHD and epilepsy is largely based...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Objective: To study the safety and efficacy of methylphenidate in children with the dual diagnosis o...
Predictors of response to methylphenidate (MPH) among 47 children with ADHD and mental retardation (...
DOI
Add to ORKG